Skip to content

NAVA Unloading - Effects on Distribution of Ventilation

Reduced Unloading in NAVA Improves Distribution of Ventilation in ICU Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02711722
Enrollment
12
Registered
2016-03-17
Start date
2015-06-30
Completion date
2016-09-30
Last updated
2016-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Failure

Keywords

Neurally adjusted ventilatory assist

Brief summary

Title: Reduced Unloading in NAVA Improves distribution of Ventilation in ICU patients. Objectives: 1. To investigate if NAVA targeted to moderate respiratory muscular unloading results in redistribution of ventilation to the dorsal regions of the lungs 2. To verify if the redistribution of ventilation translates to a better gas exchange and to a potentially lung protective ventilation strategy (lower airway pressures) 3. To verify the possibility to set NAVA at different levels of unloading, based on Neuro-Ventilatory Efficiency. Study Design: Randomised Crossover of Pressure Support and NAVA at different levels of unloading. Population: Adult Intubated patients at the Neurosurgical ICU, ventilated for more than 48h, in weaning phase from mechanical ventilation. Study duration: 2,5h Number of subjects: 12

Detailed description

Critically ill patients on mechanical ventilation are at risk for developing respiratory muscle atrophy. Partial Assist modes such Pressure Support (PS) and Neurally Adjusted Ventilatory Assist (NAVA) are developed to maintain patients´own effort in breathing. However there are no recommendations on how to set the optimal ventilator support in NAVA to avoid over- or underassistance. A previous Electrical Impedance Thomography (EIT) study has shown a redistribution of ventilation towards the dorsal regions of the lung in acute lung injury patients ventilated with NAVA, compared to PS. In the present study, the assist is targeted to different respiratory muscle unloading, predefined and based on the Neuro-Ventilatory Efficiency (NVE). The NVE will be measured at 10min intervals and NAVA level adjusted if needed, to keep constant the level of unloading in each study step. Protocol: Once enrolled, the patients are ventilated in PS (PScli1) as set by the clinician. They are then ventilated in NAVA at 3 different levels of muscle unloading in randomized order. At NAVAcli, the assist level matches to PScli1 in terms of muscle unloading. With NAVA40% and NAVA60%, the patients have 40% and 60% unloading, respectively. In the last study step the patients are back to PS (PScli2). Each patient is his/her own control and goes through the 5 ventilation periods, of 30min each. In the last 5 min of each study step, the CoV (obtained through the EIT data), blood gas samples (for oxygenation and ventilation) and ventilatory parameters are obtained and analyzed. The investigators hypothesize that 1. It is possible to set NAVA at different levels of unloading, based on NVE. 2. Moderate muscle unloading (corresponding to NAVA40%) keeps the diaphragm active and thereby leads to more dorsal distribution of ventilation compared to PScli and to higher unloading in NAVA. 3. Secondarily and as a consequence of the redistribution of ventilation, we hypothesize that the gas exchange will remain unchanged or will improve and that the airway pressures will decrease for moderate unloading (NAVA40%).

Interventions

Ventilation supported by NAVA * Blood gas analysis * Respiratory Parameters At the end of the study step Neuro-Ventilatory Efficiency and Neuro-Mechanical Efficiency are measured.

DEVICEPScli1

Pressure support set by clinicians prior to inclusion

DEVICEPScli2

Pressure support at the same level as prior to the study

Sponsors

Karolinska University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients belonging to Neurosurgical ICU * Intubated for ≥48h * Weaning phase from Mechanical Ventilation

Exclusion criteria

* bleeding disorders (PK INR\>1,5 or APTT\>50s or platelet count \<50000/µL) or * unstable intracranial pressure (ICP\>20 mmHg during the latest 8 hours) or * unstable circulation (requiring high vasopressor dose, for example Noradrenalin \>0,2µg/kg/min) or * too severe lung disease (PFI ≤ 26,7 kPa or PEEP \>10 cmH2O or FiO2\>0,5 at study entry point) or * fever\> 38,5°C or * tendency to hyperventilation (PaCO2 \< 4,5 kPa at study entry point).

Design outcomes

Primary

MeasureTime frameDescription
Center of Ventilation (CoV), expressed in percent (ventral to dorsal)Total study time is 2,5 hoursThe distribution of ventilation is summarized by the CoV, a parameter obtained by the EIT monitor. Recordings are made at the end of each study step (total 5), lasting 30min.

Secondary

MeasureTime frameDescription
Gas Exchange (PaO2 and PaCO2)During the last 5min of each study step (each 30min), total 5 steps. Total study time 2,5 hoursComparison between study steps
Airway Pressure2,5 hours
Muscle unloading based on Neuro-Ventilatory Efficiency and Neuro-Mechanica Efficiency2,5 hours

Countries

Sweden

Contacts

Primary ContactPeter V Sackey, MD, PhD
peter.sackey@karolinska.se+46851772066
Backup ContactFrancesca Campoccia Jalde, MD
francesca.campoccia-jalde@karolinska.se0046703947741

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026